Episode Details
Back to Episodes
NanoViricides' NV-387 Near FDA Approval, LivingPhoenix Unveils Collagen Breakthrough, Octopus Arms Drive Robotics Innovation, Scientists Win Lasker Award, and more...
Published 7 months ago
Description
(0:10): NanoViricides' NV-387 Antiviral Advances Toward FDA Approval, Promises Billions in Stockpiling Contracts
(2:41): LivingPhoenix's POGMENT Collagen Revolutionizes Bioengineering with Major Scientific Recognition and Global Expansion
(5:09): Octopus Arms Inspire Next-Gen Robotics with Their Flexibility and Precision
(7:10): Scientists Win 2025 Lasker Award for Breakthrough Cystic Fibrosis Therapy Trikafta
(9:29): Revolutionary MRI Method Could Transform Prostate Cancer Screening with Faster, Cheaper, and Safer Scans
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: EurekAlert!
(2:41): LivingPhoenix's POGMENT Collagen Revolutionizes Bioengineering with Major Scientific Recognition and Global Expansion
(5:09): Octopus Arms Inspire Next-Gen Robotics with Their Flexibility and Precision
(7:10): Scientists Win 2025 Lasker Award for Breakthrough Cystic Fibrosis Therapy Trikafta
(9:29): Revolutionary MRI Method Could Transform Prostate Cancer Screening with Faster, Cheaper, and Safer Scans
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: EurekAlert!